ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2016 American Transplant Congress

    Impact of Everolimus and Low-Dose Ciclosporin on Cytomegalovirus Replication and Disease in Pediatric Renal Transplantation.

    B. Höcker,1 S. Zencke,1 L. Pape,2 K. Krupka,1 L. Kösters,1 A. Fichtner,1 L. Dello Strologo,2 I. Guzzo,2 R. Topaloglu,2 B. Kranz,2 J. König,2 M. Bald,2 N. Webb,2 A. Noyan,2 H. Dursun,2 S. Marks,2 Z. Ozcakar,2 F. Thiel,2 H. Billing,2 M. Pohl,2 H. Fehrenbach,2 P. Schnitzler,1 T. Bruckner,1 L. Weber,2 R. Feneberg,2 T. Ahlenstiehl-Grunow,2 B. Tönshoff.1

    1University Children's Hospital, Heidelberg, Germany; 2Certain Research Community, Germany, Italy, Turkey, United Kingdom.

    Purpose: Preclinical studies indicate an anti-cytomegalovirus (CMV) activity of the mammalian target of rapamycin inhibitor (mTORi) everolimus (EVR), but data in pediatric renal transplant recipients…
  • 2016 American Transplant Congress

    Geographic Variability in Access to Transplant Centers for Children with End-Stage Renal Disease.

    C. Toro,1 M. Ross,1,2 D. Wiebe,2 S. Amaral.1,2

    1Pediatrics, The Children's Hospital of Phila, Philadelphia, PA; 2Biostatistics and Epidemiology, The University of Pennsylvania, Philadelphia, PA.

    Background: Kidney transplantation is the optimal treatment for pediatric end-stage renal disease (ESRD); yet, there is substantial variability in waiting times for deceased donor kidneys…
  • 2016 American Transplant Congress

    Compensating Live Kidney Donors: The Views of United States Voters.

    J. Fisher,1 T. Peters,2 R. Gish,3 R. Howard.4

    1Surgery, Scripps Center for Organ Transplantation, La Jolla, CA; 2Surgery, University of Florida, Jacksonville, FL; 3Medicine, Stanford University Medical Center, Stanford, CA; 4Surgery, LifeQuest Organ Recovery Services, Gainesville, FL.

    Purpose: An increasing number of U.S. patients die waiting for a kidney transplant. Financial compensation of living donors is one possible remedy for the organ…
  • 2016 American Transplant Congress

    The Heterogenous Genomic Landscape of Unresectable Hepatoblastoma Requiring Liver Transplantation: Prognostic Implications.

    M. Ningappa, B. Higgs, S. Ranganathan, C. Ashokkumar, R. Sindhi.

    Surgery, Children's Hospital of Pittsburgh of UPMC and University of Pittsburgh, Pittsburgh, PA.

    Background: Hepatoblastoma, the most common pediatric liver malignancy, is cured by chemotherapy and surgical resection. Locally invasive/multifocal tumors require liver transplantation (LTx). A unique tumor…
  • 2016 American Transplant Congress

    The Effect of Maternal Graft in Early Acute Cellular Rejection After Pediatric Living Donor Liver Transplantation.

    Y. Noguchi,1 T. Ueno,1 K. Bessho,2 Y. Takama,1 H. Yamanaka,1 N. Tanaka,1 Y. Tazuke,1 H. Okuyama.1

    1Pediatric Surgery, Osaka University, Suita, Osaka, Japan; 2Pediatrics, Osaka University, Suita, Osaka, Japan.

    Objectives: It has been reported that the living donor liver transplantation (LDLT) in which the patients received a maternal graft could be more successful compared…
  • 2016 American Transplant Congress

    Simultaneous Pancreas/Kidney Transplantation Increases the Risk of Late-Onset BKV-Associated Nephropathy.

    T. Schachtner,1,2 M. Zaks,1 A. Kahl,1 P. Reinke.1,2

    1Nephrology and Internal Intensive Care, Charite Campus Virchow Clinic, Berlin, Germany; 2Berlin-Brandenburg Center for Regenerative Therapies, Charite Campus Virchow Clinic, Berlin, Germany.

    Infections have increased in simultaneous pancreas/kidney transplant recipients (SPKTRs) with BKV-associated nephropathy (BKVN) being the most important infectious cause of allograft loss. Comparisons of BKVN…
  • 2016 American Transplant Congress

    Tacrolimus Precision Medicine: Antibiotics Increase Intra-Patient Variability in Tacrolimus Trough Concentrations in Kidney Transplant Recipients.

    Y. Zheng, J. Lee, A. Masand, D. Dadhania, M. Thangamani, M. Suthanthiran.

    Medicine/Nephrology and Hyeprtension, Weill Cornell Medical College, New York, NY.

    BACKGROUND. The gut microbiome impacts drug absorption, metabolism, and distribution and was recently shown to be associated with tacrolimus dosing requirements. Since antibiotics can alter…
  • 2016 American Transplant Congress

    Urgent Kidney Transplantation as Successful Treatment of Calciphylaxis in Three Patients with End-Stage Kidney Failure.

    E. Nordheim,1 D. Dahle,1 I. Syse,1 A. Åsberg,1,2 A. Reisæter,1 H. Holdaas,1 T. Jenssen,1,3 A. Hartmann.1,4

    1Transplantation Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway; 2Shool of Pharmacy, University of Oslo, Oslo, Norway; 3Kidney, Arctic University of Tromsø, Tromsø, Norway; 4Institute of Clinical Medicine, Medical Faculty, University of Oslo, Oslo, Norway.

    Background: Calciphylaxis often referred to as calcific uremic arteriolopathy (CUA) is a rare and serious complication with limited treatment options. Kidney transplantation restores kidney function…
  • 2016 American Transplant Congress

    Effect of Inflammation on Concentration of Intracellular Tacrolimus.

    E. Bae,1 S. Yang,2 S. Han,1 J.-Y. Park,1 H. Lee,1 Y. Kim.1

    1Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea; 2Kidney Research Institute, Seoul National University, Seoul, Republic of Korea.

    Background: The use of calcineurin inhibitors improved the outcome for transplant recipients. However, acute rejection (AR) and infection remained still an unsolved problem. We evaluated…
  • 2016 American Transplant Congress

    Tacrolimus Levels in Patients Treated with Direct Acting Antivirals Post-Transplant.

    J. Wiegel, T. Egbuka.

    Pharmacy, Oregon Health & Science University, Portland, OR.

    Purpose: To determine if treatment of recurrent hepatitis C virus (HCV) post-liver transplant with the direct-acting antivirals (DAAs) sofosbuvir, simeprevir, and ledipasvir (in combination and/or…
  • « Previous Page
  • 1
  • …
  • 175
  • 176
  • 177
  • 178
  • 179
  • 180
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences